A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
A phase 2 trial of Ramucirumab, Cisplatin, Gemcitabine in metastatic cancer, run by Eli Lilly and Company, active and no longer recruiting.
Overview
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer is a phase 2 interventional study registered as NCT02711553 by Eli Lilly and Company, with 309 participants enrolled, started 2016-05-19 and due to reach its primary completion in 2018-02-16. Interventions recorded: Ramucirumab, Merestinib, Cisplatin, Gemcitabine, Placebo Oral. Conditions listed: Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Shares Ramucirumab, Eli Lilly (incl. Loxo), Gemcitabine, Metastatic cancer (cancer that has spread).
- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Shares Gemcitabine, Cisplatin, Metastatic cancer (cancer that has spread).
- TrialA Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Shares Eli Lilly (incl. Loxo), Metastatic cancer (cancer that has spread).
- TrialA Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
Shares Gemcitabine, Cisplatin, Metastatic cancer (cancer that has spread).
- TrialCosiporfin Sodium for Injection Photodynamic Therapy
Shares Gemcitabine, Cisplatin.
- TrialPembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Shares Gemcitabine, Cisplatin, Metastatic cancer (cancer that has spread).
- TrialA Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Shares Cisplatin, Metastatic cancer (cancer that has spread).
- TrialA Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Shares Eli Lilly (incl. Loxo), Metastatic cancer (cancer that has spread).